Ipsen Sa Adr (IPSEY) Downgraded by Zacks Investment Research to Hold

Ipsen Sa Adr (OTCMKTS:IPSEY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday.

According to Zacks, “Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France. “

Shares of Ipsen Sa Adr (OTCMKTS:IPSEY) traded up 3.81% during midday trading on Friday, reaching $33.61. 2,705 shares of the company were exchanged. The company has a market capitalization of $11.08 billion and a P/E ratio of 44.24. Ipsen Sa Adr has a 52-week low of $14.15 and a 52-week high of $33.81. The stock has a 50-day moving average price of $30.89 and a 200 day moving average price of $23.63.

TRADEMARK VIOLATION WARNING: This piece was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2017/06/17/ipsen-sa-adr-ipsey-downgraded-by-zacks-investment-research-to-hold.html.

Receive News & Ratings for Ipsen Sa Adr Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ipsen Sa Adr and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply